BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1532509)

  • 1. Zoladex (goserelin) in the treatment of benign gynaecological disorders: an overview of safety and efficacy.
    Miller RM; Frank RA
    Br J Obstet Gynaecol; 1992 Feb; 99 Suppl 7():37-41. PubMed ID: 1532509
    [No Abstract]   [Full Text] [Related]  

  • 2. Goserelin (Zoladex) in the treatment of fibroids.
    West CP; Lumsden MA; Baird DT
    Br J Obstet Gynaecol; 1992 Feb; 99 Suppl 7():27-30. PubMed ID: 1532507
    [No Abstract]   [Full Text] [Related]  

  • 3. Monthly implant of luteinizing hormone-releasing hormone agonist: a practical therapeutic approach for sex-steroid dependent gynecologic diseases.
    Lemay A
    Fertil Steril; 1987 Jul; 48(1):10-2. PubMed ID: 2954859
    [No Abstract]   [Full Text] [Related]  

  • 4. The short-term use of luteinising hormone-releasing hormone analogues in uterine fibroids.
    Van der Spuy ZM; Fieggan AG; Wood MJ; Pienaar CA
    Horm Res; 1989; 32 Suppl 1():137-40. PubMed ID: 2533144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of treatment with LHRH analogue Zoladex on binding of oestradiol, progesterone and epidermal growth factor to uterine fibromyomata.
    Baird DT; Bramley TA; Hawkins TA; Lumsden MA; West CP
    Horm Res; 1989; 32 Suppl 1():154-6. PubMed ID: 2533146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Preoperative reduction of uterine leiomyoma by the GnRH-analog goserelin (zoladex)].
    Hackenberg R; Gesenhues T; Deichert U; Duda V; Sturm G; Schulz KD
    Geburtshilfe Frauenheilkd; 1990 Feb; 50(2):136-9. PubMed ID: 2138580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GnRH agonists-antagonists--clinical applications.
    Shaw RW
    Eur J Obstet Gynecol Reprod Biol; 1988 Jun; 28(2):109-16. PubMed ID: 2969835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New possibilities for differentiated therapy of leiomyoma of the uterus using the GnRH agonist zoladex].
    Gesenhues T; Hackenberg R; Diechert U; Duda V; Sturm G; Schulz KD
    Geburtshilfe Frauenheilkd; 1989 Feb; 49 Suppl 1():96-8. PubMed ID: 2522904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Goserelin (Zoladex) depot in the treatment of endometriosis. Zoladex Endometriosis Study Group.
    Reichel RP; Schweppe KW
    Fertil Steril; 1992 Jun; 57(6):1197-202. PubMed ID: 1534773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The management of leiomyoma uteri by GnRH analogues.
    Giorgino FL; Cetera C
    Clin Exp Obstet Gynecol; 1991; 18(2):137-43. PubMed ID: 1833095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Goserelin--depot preparation of LHRH analogue used in the treatment of endometriosis.
    Shaw RW
    Prog Clin Biol Res; 1990; 323():383-92. PubMed ID: 2137621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Goserelin. A review of its pharmacodynamic and pharmacokinetic properties, and clinical use in sex hormone-related conditions.
    Chrisp P; Goa KL
    Drugs; 1991 Feb; 41(2):254-88. PubMed ID: 1709853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shrinkage of uterine fibroids during therapy with goserelin (Zoladex): a luteinizing hormone-releasing hormone agonist administered as a monthly subcutaneous depot.
    West CP; Lumsden MA; Lawson S; Williamson J; Baird DT
    Fertil Steril; 1987 Jul; 48(1):45-51. PubMed ID: 2954863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shrinkage of uterine fibroids by preoperative LHRH analogue injection.
    McClelland HR; Quinn AJ
    Ulster Med J; 1992 Apr; 61(1):51-5. PubMed ID: 1535743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maintained reduction of uterine leiomyoma following addition of hormonal replacement therapy to a monthly luteinizing hormone-releasing hormone agonist implant: a pilot study.
    Maheux R; Lemay A; Blanchet P; Friede J; Pratt X
    Hum Reprod; 1991 Apr; 6(4):500-5. PubMed ID: 1655823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Goserelin depot: an analog of LHRH for the treatment of endometriosis].
    Shaw RW
    Drugs Exp Clin Res; 1990; 16 Suppl():69-75. PubMed ID: 2150504
    [No Abstract]   [Full Text] [Related]  

  • 17. An open randomized comparative study of the effect of goserelin depot and danazol in the treatment of endometriosis. Zoladex Endometriosis Study Team.
    Shaw RW
    Fertil Steril; 1992 Aug; 58(2):265-72. PubMed ID: 1386029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Goserelin versus danazol in the treatment of endometriosis.
    Giorgino FL; Cetera C; de Laurentiis G
    Clin Exp Obstet Gynecol; 1991; 18(2):127-31. PubMed ID: 1833094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of peri-menopausal women: potential long-term therapy with a depot GnRH agonist combined with hormonal replacement therapy.
    Maheux R; Lemay A
    Br J Obstet Gynaecol; 1992 Feb; 99 Suppl 7():13-7. PubMed ID: 1532506
    [No Abstract]   [Full Text] [Related]  

  • 20. Pretreatment with Zoladex improves surgery for uterine fibroids.
    Oncology (Williston Park); 1991 Jan; 5(1):94. PubMed ID: 1828691
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.